« Previous
Next »
American Journal of Kidney Diseases
Volume 53, Issue 5
, Pages
911-912
, May 2009
Plasma and Peritoneal Dialysate Levels During Daptomycin Therapy for Peritonitis
-
(A) Peritoneal dialysis fluid and (B) blood trough concentrations of daptomycin in a patient with Gram-positive peritoneal dialysis–associated peritonitis. Daptomycin was given intravenously at a dose
(A) Peritoneal dialysis fluid and (B) blood trough concentrations of daptomycin in a patient with Gram-positive peritoneal dialysis–associated peritonitis. Daptomycin was given intravenously at a dose of 5 mg/kg body weight every 48 hours (open arrows). Peritoneal dialysis fluid was collected at the end of 3 daytime 4-hour periods (2 L Physioneal® 2.27% each) and 1 overnight 12-hour dwell time (2 L Extraneal® 7.5% per day). Daptomycin concentrations were measured by using high-performance liquid chromatography.6 The patient's hospital discharge is indicated.
PII: S0272-6386(09)00517-4
doi: 10.1053/j.ajkd.2009.02.017
© 2009 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
« Previous
Next »
American Journal of Kidney Diseases
Volume 53, Issue 5
, Pages
911-912
, May 2009
